Home/Filings/4/0001053369-16-000040
4//SEC Filing

ELITE PHARMACEUTICALS INC /NV/ 4

Accession 0001053369-16-000040

$ELTPCIK 0001053369operating

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 7:05 PM ET

Size

5.1 KB

Accession

0001053369-16-000040

Insider Transaction Report

Form 4
Period: 2016-02-16
Hakim Nasrat A
DirectorPresident & CEO
Transactions
  • Award

    Common Stock

    2016-02-16$0.25/sh+2,854,279$699,86922,040,747 total
Holdings
  • Common Stock

    (indirect: By IRA)
    2,700,000

Issuer

ELITE PHARMACEUTICALS INC /NV/

CIK 0001053369

Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0001053369

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 7:05 PM ET
Size
5.1 KB